88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

CJ BIO to Showcase TasteNrich® Taste Lab for Sodium Reduction, Clean Label, and Taste Design Solutions at IFT FIRST 2026 "Not Just Reducing, But Designing Better Taste" ... 2026-06-22T Biotechnology Health Care/Hospital Retail
CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors SHANGHAI , June 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that as informed by the ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors SHANGHAI , June 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that as informed by the ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ChemT Biotechnology Raises US$5 Million in 18 months to bring AI to Biomanufacturing The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavemaker Ventures, with participation by SEEDS, further supported by notable ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes. ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innogen Pharmaceutical Group Highlights China-Originated Innovation and Global Development Strategy at DIA Global Annual Meeting 2026 China Town Hall From original GLP-1 science to international clinical development, Innogen shares its "from 0 to 1" innovation journey in metabolic diseases ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell — The study shows that EGFR-TKIs induce TROP2 upregulation in DTP cells, providing a mechanistic basis for combining sac-TMT with EGFR-TKI. ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Medicine And SK Biopharmaceuticals Achieved AI-powered Drug Discovery Collaboration Worth Up to 2.5 Billion for Neuroimmune Disorders CAMBRIDGE, Mass. , June 22, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK ), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceuticals, ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE ATG-106 is a first-in-class CDH6 x CD3 bispecific T cell engager (TCE) in preclinical development for the treatment of solid tumors K2 Therapeutics, established by MPM BioImpact, ... 2026-06-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use INCHEON, South Korea and SAN DIEGO , June 22, 2026 /PRNewswire/ -- LOTTE Biologics announced that it has completed major construction and obtained approval for use for Plant 1 at its Songdo Bio ... 2026-06-22T Biotechnology Construction/Building Health Care/Hospital

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved